Cardiac myosin-binding protein C as a biomarker of acute myocardial infarction.
作者信息
Marber Michael S, Mills Nicholas L, Morrow David A, Mueller Christian
机构信息
School of Cardiovascular Medicine and Sciences, The Rayne Institute, 4th Floor Lambeth Wing, St Thomas' Hospital, London SE1 7EH, UK.
British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
出版信息
Eur Heart J Acute Cardiovasc Care. 2021 Oct 27;10(8):963-965. doi: 10.1093/ehjacc/zuab086.
Abstract
摘要
相似文献
1
Cardiac myosin-binding protein C as a biomarker of acute myocardial infarction.
Eur Heart J Acute Cardiovasc Care. 2021 Oct 27;10(8):963-965. doi: 10.1093/ehjacc/zuab086.
2
Cardiac Myosin-Binding Protein C-From Bench to Improved Diagnosis of Acute Myocardial Infarction.
Cardiovasc Drugs Ther. 2019 Apr;33(2):221-230. doi: 10.1007/s10557-018-6845-3.
3
Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction.
J Mol Cell Cardiol. 2012 Jan;52(1):154-64. doi: 10.1016/j.yjmcc.2011.09.011. Epub 2011 Sep 19.
4
Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis.
Mol Cell Proteomics. 2009 Dec;8(12):2687-99. doi: 10.1074/mcp.M900176-MCP200. Epub 2009 Aug 31.
5
Surviving the infarct: A profile of cardiac myosin binding protein-C pathogenicity, diagnostic utility, and proteomics in the ischemic myocardium.
Proteomics Clin Appl. 2014 Aug;8(7-8):569-77. doi: 10.1002/prca.201400011. Epub 2014 Jul 14.
6
Myocardial infarction-induced N-terminal fragment of cardiac myosin-binding protein C (cMyBP-C) impairs myofilament function in human myocardium.
J Biol Chem. 2014 Mar 28;289(13):8818-27. doi: 10.1074/jbc.M113.541128. Epub 2014 Feb 7.
7
Comparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury.
Circ Res. 2019 Jul 19;125(3):328-340. doi: 10.1161/CIRCRESAHA.119.314937. Epub 2019 Jun 4.
8
Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction.
Circulation. 2017 Oct 17;136(16):1495-1508. doi: 10.1161/CIRCULATIONAHA.117.028084. Epub 2017 Sep 26.
9
Cardiac Myosin-Binding Protein C to Diagnose Acute Myocardial Infarction in the Pre-Hospital Setting.
J Am Heart Assoc. 2019 Aug 6;8(15):e013152. doi: 10.1161/JAHA.119.013152. Epub 2019 Jul 26.
10
Release kinetics of circulating cardiac myosin binding protein-C following cardiac injury.
Am J Physiol Heart Circ Physiol. 2014 Feb 15;306(4):H547-56. doi: 10.1152/ajpheart.00846.2013. Epub 2013 Dec 13.
引用本文的文献
1
Body-wide expression profiles of commonly assessed cardiac biomarkers in a large cohort of human tissue donors.
Cardiology. 2025 Jul 8:1-28. doi: 10.1159/000547289.
2
Cardiac myosin binding protein C correlate with cardiac troponin I during an exercise training program in patients with HFrEF.
ESC Heart Fail. 2025 Jun;12(3):2382-2386. doi: 10.1002/ehf2.15222. Epub 2025 Jan 23.
3
The Role of Cardiac Troponin and Other Emerging Biomarkers Among Athletes and Beyond: Underlying Mechanisms, Differential Diagnosis, and Guide for Interpretation.
Biomolecules. 2024 Dec 19;14(12):1630. doi: 10.3390/biom14121630.
4
Prognostic value of combining cardiac myosin-binding protein C and N-terminal pro-B-type natriuretic peptide in patients without acute coronary syndrome treated at medical cardiac intensive care units.
Heart Vessels. 2025 Jun;40(6):531-544. doi: 10.1007/s00380-024-02492-5. Epub 2024 Dec 4.
5
Etiology of genetic muscle disorders induced by mutations in fast and slow skeletal MyBP-C paralogs.
Exp Mol Med. 2023 Mar;55(3):502-509. doi: 10.1038/s12276-023-00953-x. Epub 2023 Mar 1.
6
Implications of S-glutathionylation of sarcomere proteins in cardiac disorders, therapies, and diagnosis.
Front Cardiovasc Med. 2023 Jan 24;9:1060716. doi: 10.3389/fcvm.2022.1060716. eCollection 2022.
7
From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction.
Int J Mol Sci. 2022 Aug 15;23(16):9168. doi: 10.3390/ijms23169168.
8
Cardiac Complications of Hypertensive Emergency: Classification, Diagnosis and Management Challenges.
J Cardiovasc Dev Dis. 2022 Aug 17;9(8):276. doi: 10.3390/jcdd9080276.
本文引用的文献
1
Cardiac myosin-binding protein C in the diagnosis and risk stratification of acute heart failure.
Eur J Heart Fail. 2021 May;23(5):716-725. doi: 10.1002/ejhf.2094. Epub 2021 Feb 5.
2
Comparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury.
Circ Res. 2019 Jul 19;125(3):328-340. doi: 10.1161/CIRCRESAHA.119.314937. Epub 2019 Jun 4.
3
Cardiac Myosin-Binding Protein C-From Bench to Improved Diagnosis of Acute Myocardial Infarction.
Cardiovasc Drugs Ther. 2019 Apr;33(2):221-230. doi: 10.1007/s10557-018-6845-3.
4
High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial.
Lancet. 2018 Sep 15;392(10151):919-928. doi: 10.1016/S0140-6736(18)31923-8. Epub 2018 Aug 28.
5
Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction.
Circulation. 2017 Oct 17;136(16):1495-1508. doi: 10.1161/CIRCULATIONAHA.117.028084. Epub 2017 Sep 26.
Zotero 插件